Therapeutic Asset Ratings

502 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
azd6234 Liver Disorder	AstraZeneca	P1	CC (43)
azd6738 Neoplasm	AstraZeneca	P1	CC (43)
azd7503 Steatohepatitis	AstraZeneca	P1	CC (43)
azd9550 Liver Disorder	AstraZeneca	P1	CC (43)
azd9592 Advanced Solid Tumours	AstraZeneca	P1	CC (43)
Carboplatin High Grade Malignant Neoplasm	AstraZeneca	P1	CC (43)
Ceralasertib High Grade Malignant Neoplasm	AstraZeneca	P1	CC (43)
Ceralasertib Neoplasm	AstraZeneca	P1	CC (43)
Cetuximab Advanced Solid Tumours	AstraZeneca	P1	CC (43)
Drug X Advanced Solid Tumours	AstraZeneca	P1	CC (43)
Durvalumab High Grade Malignant Neoplasm	AstraZeneca	P1	CC (43)
Fpi-2053 Non-Small Cell Lung Carcinoma	AstraZeneca	P1	CC (43)
Fpi-2053 Colorectal Carcinoma	AstraZeneca	P1	CC (43)
IMMUNOGLOBULIN G1 (134-CYSTEINE,228-VALINE,242-PHENYLALANINE,243-GLUTAMIC ACID,339-SERINE,362-CYSTEINE,374-TRYPTOPHAN), ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN MONOCLONAL MEDI5752 .GAMMA.1-CHAIN), DISULFIDE WITH (122-CYSTEINE,212-VALINE) HUMAN MONOCLONAL MEDI5752 .LAMBDA.-CHAIN, (234->231')(237->234')(362->354') TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (239-PHENYLALANINE,240-GLUTAMIC ACID,336-SERINE,354-CYSTEINE,371-SERINE,373-ALANINE,412-VALINE) ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL MEDI5752 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MEDI5752 .KAPPA.-CHAIN Non-Small Cell Lung Carcinoma	AstraZeneca	P1	CC (43)
Itraconazole Primary Peritoneal Carcinoma	AstraZeneca	P1	CC (43)
MOXIFLOXACIN Metabolic Dysfunction-Associated Steatohepatitis	AstraZeneca	P1	CC (43)
Olaparib High Grade Malignant Neoplasm	AstraZeneca	P1	CC (43)
Osimertinib Advanced Solid Tumours	AstraZeneca	P1	CC (43)
(+)-VINCRISTINE Advanced Solid Tumours	AstraZeneca	P1	CC (43)
azd0516 Metastatic Prostate Carcinoma	AstraZeneca	P1/2	CC (43)
azd0754 Metastatic Prostate Carcinoma	AstraZeneca	P1/2	CC (43)
azd3470 Non-Hodgkin Lymphoma	AstraZeneca	P1/2	CC (43)
azd4360 Biliary Tract Cancer	AstraZeneca	P1/2	CC (43)
azd5305 Urinary Bladder Carcinoma	AstraZeneca	P1/2	CC (43)
azd5863 Esophageal Adenocarcinoma	AstraZeneca	P1/2	CC (43)

Showing 301 to 325 of 502 assets

PreviousPage 13 of 21Next